Solid Biosciences Inc. ($SLDB)
Filing Information
| Accession Number | 0001193125-26-034080 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 3, 2026 |
| Document Date | Jan 29, 2026 |
| Document | View SEC Filing |
Transactions
7
Total Shares
596,303
Total Value
$243,128.15
P&L
+inf% (+$2,244,936.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Jan 29, 2026 | Exercise/Conversion | 79,341 | โ | โ | 112,249 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Jan 31, 2026 | Exercise/Conversion | 42,275 | โ | โ | 154,254 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 2, 2026 | Sale | 37,771 | $6.44 | $243,128.15 | 116,753 | Direct | โ | View Details | |
Chief Operating Officer | Performance Stock Units | Derivative | Jan 29, 2026 | Exercise/Conversion | 79,341 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Employee Stock Option (Right to Buy) | Derivative | Jan 29, 2026 | Grant/Award | 210,200 | $0.00 | $0.00 | 210,200 | Direct | โ | View Details | |
Chief Operating Officer | Restricted Stock Units | Derivative | Jan 29, 2026 | Grant/Award | 105,100 | $0.00 | $0.00 | 105,100 | Direct | โ | View Details | |
Chief Operating Officer | Restricted Stock Units | Derivative | Jan 31, 2026 | Exercise/Conversion | 42,275 | $0.00 | $0.00 | 126,825 | Direct | โ | View Details |